EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

By M. Sant, C. Allemani, M. Santaquilani, A. Knijn, F. Marchesi, R. Capocaccia. European Journal of Cancer, 2009

889 citations recorded by the source corpus.

Subfields: Epidemiology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/b86fa2b3ba7fecc45449007a593623f76c6f6d98

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Alexandra G. Smith
2. Jacques Estève
3. D. Howell
4. Janez Stare
5. Eve Roman
6. Andrew Jack
7. Maja Pohar Perme
8. R. Patmore

Citations in the corpus

• On Estimation in Relative Survival (2012, methodology): “It is a method to measure cancer survival after elimination of the influence of other causes of death in large-scale multinational survival studies as EUROCARE or CONCORD (Coleman et al., 2008; Sant et al., 2009), where population survival differs substantially between countries.”
• Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network (2011, background): “…population, as well as the application of appropriate disease classifications, and it is the attainment of these two key components that continues to beleaguer epidemiological research into the haematological malignancies (National Institute for Clinical Excellence, 2003; Sant et al, 2009, 2010).”